Charlotta Hedner
Inga Maria Nilsson's Street 53
Malmoe, M 21428, Sweden
Malmoe, M 21428, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: January 22, 2024
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers.
Journal: EBioMedicine
Published: August 29, 2022
High Infiltration of CD68+/CD163- Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma.
Journal: Journal of innate immunity
Published: October 19, 2021
T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy: relationship with histopathological response and survival.
Journal: Oncoimmunology
Published: June 09, 2021
Development of a Novel Weighted Ranking Method for Immunohistochemical Quantification of a Heterogeneously Expressed Protein in Gastro-Esophageal Cancers.
Journal: Cancers
Published: December 22, 2020
Tumor-Associated CD68+, CD163+, and MARCO+ Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma.
Journal: Frontiers in oncology
Published: February 13, 2020
Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naïve Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival.
Journal: Frontiers in oncology
Published: November 22, 2018
Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma.
Journal: Journal of translational medicine
Published: May 04, 2018
Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
Journal: Journal of clinical pathology
Published: September 05, 2017
The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma.
Journal: Oncotarget
Published: February 24, 2017
Prognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma.
Journal: Journal of gastrointestinal oncology
Published: January 13, 2017
Last Updated: 09/26/2026